Pregnancy: Pregnancy Category B. Reproduction studies have been performed in rats and rabbits at doses of 50 mg/kg and have revealed no evidence of impaired fertility or harm to the fetus due to administration of sodium hyaluronate. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should only be used during pregnancy if clearly needed.
Lactation: Caution should be exercised when HYATEAR is administered to a nursing woman.